Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Tamm-Horsfall protein augments neutrophil NETosis during urinary tract infection
Vicki Mercado-Evans, Holly Branthoover, Claude Chew, Camille Serchejian, Alexander B. Saltzman, Marlyd E. Mejia, Jacob J. Zulk, Ingrid Cornax, Victor Nizet, Kathryn A. Patras
Vicki Mercado-Evans, Holly Branthoover, Claude Chew, Camille Serchejian, Alexander B. Saltzman, Marlyd E. Mejia, Jacob J. Zulk, Ingrid Cornax, Victor Nizet, Kathryn A. Patras
View: Text | PDF
Research Article Immunology Infectious disease

Tamm-Horsfall protein augments neutrophil NETosis during urinary tract infection

  • Text
  • PDF
Abstract

Urinary neutrophils are a hallmark of urinary tract infection (UTI), yet the mechanisms governing their activation, function, and efficacy in controlling infection remain incompletely understood. Tamm-Horsfall glycoprotein (THP), the most abundant protein in urine, uses terminal sialic acids to bind an inhibitory receptor and dampen neutrophil inflammatory responses. We hypothesized that neutrophil modulation is an integral part of THP-mediated host protection. In a UTI model, THP-deficient mice showed elevated urinary tract bacterial burdens, increased neutrophil recruitment, and more severe tissue histopathological changes compared with WT mice. Furthermore, THP-deficient mice displayed impaired urinary NETosis during UTI. To investigate the effect of THP on NETosis, we coupled in vitro fluorescence-based NET assays, proteomic analyses, and standard and imaging flow cytometry with peripheral human neutrophils. We found that THP increases proteins involved in respiratory chain, neutrophil granules, and chromatin remodeling pathways; enhances NETosis in an ROS-dependent manner; and drives NET-associated morphologic features including nuclear decondensation. These effects were observed only in the presence of a NETosis stimulus and could not be solely replicated with equivalent levels of sialic acid alone. We conclude that THP is a critical regulator of NETosis in the urinary tract, playing a key role in host defense against UTI.

Authors

Vicki Mercado-Evans, Holly Branthoover, Claude Chew, Camille Serchejian, Alexander B. Saltzman, Marlyd E. Mejia, Jacob J. Zulk, Ingrid Cornax, Victor Nizet, Kathryn A. Patras

×

Figure 6

THP modestly alters neutrophil responses to PMA stimulation.

Options: View larger image (or click on image) Download as PowerPoint
THP modestly alters neutrophil responses to PMA stimulation.
(A) NETosis...
(A) NETosis was assessed by released dsDNA (detected by PicoGreen dye) and expressed as arbitrary units (AU) of fluorescence normalized to mock-treated, unstimulated controls. Neutrophils were subjected to tandem mass tag-based proteomics profiling. (B) Principal component analysis of neutrophils that were untreated (UnTx), treated with THP (THP), untreated with PMA stimulation (PMA), and THP-treated with PMA stimulation (THP+PMA). Points represent individual samples, colored by treatment, with paired donor samples indicated by matched symbol. (C) Venn diagram of proteins differentially detected in THP-treated samples compared with untreated samples in PMA-stimulated (PMA and THP+PMA) and unstimulated (UnTx and THP) conditions. (D and E) Volcano plot (D) and gene set enrichment analysis (E) of differential proteins in untreated versus THP-treated samples. (F and G) Volcano plot (F) and gene set enrichment analysis (G) of differential proteins in PMA versus THP+PMA samples. Experiments were performed independently 3 times and combined, n = 5 (A), or as one independent experiment, n = 4 (B–G). Bar plots show median, all points, and 95% CI (A). Data were analyzed by 2-way ANOVA with Šídák’s multiple-comparisons test (A). Differential proteins (C–G) were identified via log2 fold change > 1.25 and moderated 2-tailed t test followed by multiple-hypothesis testing correction using the Benjamini-Hochberg procedure with a FDR-adjusted P < 0.05. Individual proteins are listed in Supplemental Table 2.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts